It is possible, and should be experimentally investigated, that p53 cellular compartmentalization is different in CML progenitors versus primitive CML CD34+ CD38− stem cells. This evidence concerns the gene CD38 and chronic myelogenous leukemia, BCR-ABL1 positive.